CymaBay Therapeutics Inc. (CBAY)
Total Valuation
CBAY has a market cap or net worth of $234.56 million. The enterprise value is $125.22 million.
Market Cap | 234.56M |
Enterprise Value | 125.22M |
Important Dates
The next earnings date is Thursday, August 11, 2022, after market close.
Estimated Earnings Date | Aug 11, 2022 |
Ex-Dividend Date | n/a |
Share Statistics
CBAY has 84.68 million shares outstanding. The number of shares has increased by 27.35% in one year.
Shares Outstanding | 84.68M |
Shares Change (YoY) | +27.35% |
Shares Change (QoQ) | +13.64% |
Owned by Insiders (%) | 0.39% |
Owned by Institutions (%) | 79.38% |
Float | 62.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 2.18 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.68, with a Debt / Equity ratio of 0.74.
Current Ratio | 13.68 |
Quick Ratio | 13.43 |
Debt / Equity | 0.74 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -92.30%, which is considered low. The company has a ROIC of -85.00%.
Return on Equity (ROE) | -92.30% |
Return on Assets (ROA) | -62.40% |
Return on Capital (ROIC) | -85.00% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.70M |
Employee Count | 59 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.47% in the last 52 weeks. The beta is 1.08, so CBAY's price volatility has been similar to the market average.
Beta (1Y) | 1.08 |
52-Week Price Change | -36.47% |
50-Day Moving Average | 2.20 |
200-Day Moving Average | 2.82 |
Average Volume (30 Days) | 790,070 |
Short Selling Information
The latest short interest is 3.35 million, so 3.95% of the outstanding shares have been sold short.
Short Interest | 3.35M |
Short % of Shares Out | 3.95% |
Short % of Float | 5.38% |
Short Ratio (days to cover) | 5.45 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -94.47M |
Net Income | -100.22M |
EBITDA | -93.58M |
EBIT | -94.27M |
Earnings Per Share (EPS) | -$1.32 |
Balance Sheet
The company has $188.56 million in cash and $79.22 million in debt, giving a net cash position of $109.34 million or $1.29 per share.
Cash & Cash Equivalents | 188.56M |
Total Debt | 79.22M |
Net Cash | 109.34M |
Net Cash Per Share | $1.29 |
Book Value | 107.38M |
Book Value Per Share | 1.27 |
Working Capital | 178.01M |
Cash Flow
In the last 12 months, operating cash flow was -$74.23 million and capital expenditures $7,000, giving a free cash flow of -$74.23 million.
Operating Cash Flow | -74.23M |
Capital Expenditures | 7,000 |
Free Cash Flow | -74.23M |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CBAY does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Earnings Yield | -42.73% |
FCF Yield | -31.64% |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Buyback Yield | -27.35% |
Shareholder Yield | -27.35% |
Analyst Forecast
The average price target for CBAY is $10.09, which is 264.26% higher than the current price. The consensus rating is "Buy".
Price Target | $10.09 |
Price Target Difference | 264.26% |
Analyst Consensus | Buy |
Analyst Count | 14 |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |